Genes encoding plant nucleotide-binding leucine-rich repeat (NB-LRR) proteins confer dominant resistance to diverse pathogens. The wild-type potato NB-LRR protein Rx confers resistance against a single strain of potato virus X (PVX), whereas LRR mutants protect against both a second PVX strain and the distantly related poplar mosaic virus (PopMV). In one of the Rx mutants there was a cost to the broad-spectrum resistance because the response to PopMV was transformed from a mild disease on plants carrying wild-type Rx to a trailing necrosis that killed the plant. To explore the use of secondary mutagenesis to eliminate this cost of broadspectrum resistance, we performed random mutagenesis of the Nterminal domains of this broad-recognition version of Rx and isolated four mutants with a stronger response against the PopMV coat protein due to enhanced activation sensitivity. These mutations are located close to the nucleotide-binding pocket, a highly conserved structure that likely controls the "switch" between active and inactive NB-LRR conformations. Stable transgenic plants expressing one of these versions of Rx are resistant to the strains of PVX and the PopMV that previously caused trailing necrosis. We conclude from this work that artificial evolution of NB-LRR disease resistance genes in crops can be enhanced by modification of both activation and recognition phases, to both accentuate the positive and eliminate the negative aspects of disease resistance.
plant immunity | genetically modified | arms race | NLR | plant defense P lant resistance (R) genes confer dominant resistance against diverse pests and pathogens including viruses, fungi, and invertebrates (1) . The vast majority of R genes encode NB-LRR (nucleotide-binding leucine-rich repeat) proteins (2) that form a subgroup within the STAND ATPases (signal transduction ATPases with numerous domains) (3) . NB-LRRs are thought to function as a molecular switch, existing in ATP-bound "active" or ADP-bound "inactive" states (4-7). Activated NB-LRRs initiate a downstream signaling cascade triggering defense responses, which often culminate in a form of programmed cell death know as the hypersensitive response (HR) (8) .
Activation of NB-LRRs occurs following molecular recognition in which a pathogen-derived elicitor interacts, either directly or indirectly, with the LRR and/or other domains of the protein (9) (10) (11) (12) (13) (14) (15) . In different R proteins the molecular mechanisms may vary but, in Rx from potato (16) , which confers resistance to potato virus X (PVX), the domains required to initiate downstream signaling (17, 18) are likely exposed by conformational changes (19, 20) following recognition.
NB-LRR genes represent a useful target for generating diseaseresistant crops, and have long been selected unknowingly by crop breeders. More recently, transgenic approaches have been used to transfer R genes between plant species (21) (22) (23) . However, the usefulness of NB-LRR genes in both conventional breeding and transgenic approaches is limited by the availability of R protein genes with useful recognition specificities. In addition, there may be a cost to carrying NB-LRR R genes. The disease-resistant plants may have reduced fitness in competition with susceptible plants (24) , there may be a tradeoff with plant growth (25) , the plants may exhibit hybrid incompatibility (26) , or they may exhibit a partial resistance against some strains of pathogen so that there is a spreading necrosis that kills the plant (27) (28) (29) (30) .
Artificial evolution through random mutagenesis has been explored previously as a strategy to expand the number of useful variants of Rx (27) . The evolved products were forms of Rx with mutant LRR domains that recognized more strains of PVX than the wild-type protein. The elicitor of Rx-mediated resistance is the viral coat protein (CP), and the wild-type protein responds to strains in which there is a T and a K at positions 121 and 127, respectively (CP TK ), but not those with a K and an R at these positions (CP KR ) (31) . The artificial evolution focused on the LRR domain (27) , and the selected mutants were elicited by both CP KR and the original CP TK . However, this broad recognition had a cost in that one of the mutants, RxM1 (N846D), displayed systemic necrosis when the plants were challenged with poplar mosaic virus (PopMV). This virus is a distant relative of PVX, and on plants with wild-type Rx, or without Rx, it only induces a mild mosaic. To explain the lethal symptom associated with PopMV on RxM1 plants we proposed that the mutation mediated weak recognition of a PopMV structure that was invisible to the wild-type Rx. The systemic necrosis would have arisen because the weak recognition by Rx triggers a delayed HR response that is too late to prevent spread of the virus from the site of initial infection.
This side effect of the M1 mutation illustrates the balance between the costs and benefits of disease resistance, and it created an opportunity to find out whether artificial evolution could be used to reduce the costs associated with disease resistance of NB-LRR proteins. Our approach was random mutagenesis of RxM1 combined with selection for response to the PopMV coat protein rather than CP KR . In addition, rather than the LRR, we mutagenized the amino-terminal coiled coil (CC), NB, and ARC (shared by Apaf-1, resistance genes, and CED-4) domains. By selecting mutants with enhanced recognition of PopMV, we predicted to isolate mutants that give a strong and rapid response to this virus and eliminate the spreading HR. By focusing on domains other than the LRR, we reasoned that we would avoid compromising the beneficial aspects of the RxM1 phenotype.
Here we describe five amino acid changes that gave the selected response to the PopMV-CP. These mutants increase the activation sensitivity rather than the recognition phase of the Rx resistance mechanism and, from protein modeling, we conclude that they are localized around the conserved ATPase nucleotidebinding pocket. Transgenic plants containing these versions of Rx retained broad-spectrum resistance against PVX strains and PopMV without systemic necrosis: The cost of RxM1 resistance had been eliminated. The results show that Rx can be enhanced by a stepwise process that targets both recognition and activation mechanisms. Based on these results, we suggest that artificial evolution could be a useful enhancement of all disease resistance that is to be transferred by genetic manipulation of NB-LRRs.
Results
Artificial Evolution Screen Across RxM1 N-Terminal Domains. R genes can be coexpressed with cognate pathogen proteins in leaf segments of Nicotiana tabacum or N. benthamiana using an Agrobacterium-mediated transient expression assay (32) . If the R gene recognizes the pathogen protein, a hypersensitive response is induced that manifests as necrosis in the infiltrated leaf segment. RxM1 does not induce HR when transiently coexpressed with the coat protein of PopMV (PopMV-CP), but RxM1 transgenic plants display trailing necrosis when infected with PopMV, and electrolyte leakage assays suggest that RxM1 mounts a delayed response to PopMV (27) .
To find versions of RxM1 with an accelerated PopMV response, we generated a library of 1,500 RxM1 variants by randomly mutagenizing the N-terminal CC-NB-ARC1-ARC2 domains (Fig.  1A) at an error rate of 5.1 bp changes per 1.5-kb molecule, ensuring an average coverage of ∼5 bp changes per position. The selection was by transient coexpression of these mutants with PopMV-CP. The weak recognition of PopMV-CP by RxM1 does not lead to visible necrosis but, of the 1,500 RxM1 variants, we identified 22 RxM1 mutants that produce a necrotic response (Table S1 ). Of these, there were 18 candidates that also produce a necrotic response when coexpressed with GFP, indicating that these mutations cause constitutive activation of the protein. The remaining four clones, denoted RxS1*M1, RxS2*M1, RxS3*M1, and RxS4M1, induced necrosis when coexpressed with PopMV-CP but no necrosis when coexpressed with GFP ( Fig. 1 B and C and Fig. S1A ) and were selected for further analysis. The basis for this nomenclature is explained in later sections of this text: "S" is for "sensitized," and the asterisk indicates that the mutants contain more than one amino acid change.
We used a chlorophyll content assay to quantify the level of necrosis induced by different Rx variant/elicitor combinations after transient expression in N. tabacum (33) . The four candidates, RxS1*M1, RxS2*M1, RxS3*M1, and RxS4M1, retained broad recognition of PVX-CP, producing a strong necrotic response when coexpressed with both versions of the PVX coat protein, PVX-CP TK and PVX-CP KR (Fig. 1C) . The RxM123 construct, which contains three previously identified broad recognition-conferring mutations combined in the LRR domain (N846D, N796D, and L607P, respectively) was used as a positive control for recognition of PopMV-CP (27) . Western blots of infiltrated leaf tissue indicated that the mutations in RxS1*M1, RxS2*M1, RxS3*M1, and RxS4M1 do not increase Rx protein stability (Fig. S1B ). This control observation rules out that the phenotypes are due to enhanced accumulation of the mutant NB-LRR proteins.
Sensitized Mutations Are Close to the ATP/ADP Binding Site. The RxS1*M1, RxS2*M1, and RxS3*M1 proteins each contain more than one amino acid change in addition to M1 (N846D). RxS1*M1 contains four mutations (L179M, R291C, M293L, K482N); RxS2*M1 contains three (E55K, T178A, P187Q); RxS3*M1 contains four (A88T, N147D, V337A, V362I); and RxS4M1 contains only one (G340R) ( Fig. 2A, Fig. S2A , and Table S1 ). To determine which amino acid changes are responsible for the PopMV-CP response in the RxS1*M1, RxS2*M1, and RxS3*M1 clones, we used site-directed mutagenesis to generate single-amino acid change constructs corresponding to each mutation.
All single-amino acid change constructs produced functional proteins that respond to PVX coat proteins in transient expression assays (Fig. S2B) . The M293L (referred to as S1) and T178A (referred to as S2) single mutations were necessary and sufficient to recapitulate the phenotypes of RxS1*M1 and RxS2*M1, respectively, whereas for RxS3*M1, both N147D and V337A (together referred to as S3) were required (Figs. S2C and S3). As there was only one newly introduced amino acid change in RxS4M1 (G340R), this mutation is referred to as S4.
The five amino acid changes in these four mutants (S1-4) are located in the NB and ARC1 domains of Rx and are dispersed on the primary structure ( Fig. 2A and Fig. S4 ). However, when these residues are mapped onto a 3D homology model of the Rx NB-ARC1-ARC2 domains, these positions colocalize around the nucleotide-binding pocket ( Fig. 2B) (20) . The N147D and V337A mutations (derived from RxS3*M1) are positioned on opposite sides of the nucleotide, in motifs that appear together in the ATPase family phylogeny (34) . N147D is located in the characteristic STAND ATPase hhGRExE motif of the NB domain (34) and V337A is located in the GxP motif, which provides the main contribution of the ARC1 domain to the nucleotide-binding pocket. The G340R mutation (S4) in RxS4M1 is also located in the GxP motif. A direct contact of this residue with the nucleotide is not likely, but the change from a small glycine to a large positively charged arginine may affect the structure of ARC1, the interaction of the GxP motif with the nucleotide, and/or the interaction with ARC2. The M293L mutation (S1) in RxS1*M1 lies just outside the nucleotide-binding pocket, in a linker between the fifth β-strand of NB and the first α-helix of ARC1, as part of the RNBS-C motif (35) . The T178A mutation identified in RxS2*M1 (S2) is located in the P-loop motif of the NB domain, immediately C-terminal to the GKT sequence. The P loop is highly conserved and plays an important role in nucleotide binding (6, 34, 36) . Although most mutations in the P loop cause loss of function, a mutation in the T178A homologous position in the tomato NB-LRR, Mi-1.2 (T557S), causes autoactivation (37).
Mutations Increase Activation Sensitivity. The increased response to PopMV-CP in the RxM1 mutants could be due either to improved recognition of the elicitor or to increased activation sensitivity. To test these hypotheses, we exploited the weak HR induced when either Rx or RxM1 is overexpressed in the absence of CP elicitor (27, 38) . If the mutations affect activation, then overexpression in the absence of elicitor should produce more robust HR than RxM1 when overexpressed. Alternatively, if the mutations affect recognition of the elicitor, then overexpression-induced HR should remain unchanged: the phenotype would be dependent on the presence of elicitor. In each instance, the overexpression of RxS1M1, RxS2M1, RxS3M1, and RxS4M1 from the strong CaMV 35S promoter produced a more rapid and robust HR in N. tabacum leaf segments than 35S::RxM1 (Fig. S5A) .
In an additional test of elicitor-independent HR, we coexpressed the original Rx promoter constructs with RanGAP2, an Rx cytoplasmic retention factor causing overaccumulation of Rx in the cytoplasm and mild HR with Rx (39, 40) . As in the overexpression assay, each of the S1-4 mutants produced a stronger HR than RxM1 (Fig. S5B) . These findings suggest that the S1-4 mutations increase the sensitivity for activation of the NB-LRR protein rather than via improved specific recognition of PopMV-CP.
In a third test, we replaced the M1 LRR mutation (N846D) with the wild-type LRR sequence (N846) in S1-4 mutants and coexpressed them with PopMV-CP. If these mutations had enhanced the recognition of PopMV-CP, there would have been an HR in the absence of the M1 mutation. However, none of these constructs without M1 produced a robust HR on coexpression with PopMV-CP (Fig. 3A) . However, with the coat protein from the resistance-breaking PVX isolate PVX-CP KR , HR was enhanced in the absence of the M1 mutation (Fig. 3B) . Presumably, the wild-type Rx has weak recognition of CP KR that is sensitized by the S1-4 mutants.
In a fourth test of sensitization, we assayed the phenotype of RxS1234M1 and RxS1234 mutants that carry all five S mutations (Fig. 4A) . We predicted that the combined effects of these mutants on sensitization would result in a necrotic response in the absence of an elicitor, whereas recognition-mediated phenotypes would be elicitor-dependent. The results were in line with the sensitization model (Fig. 4B) . Thus, all four tests reinforce our conclusion that the M1 and S1-4 mutations affect different stages of the Rx resistance mechanism: M1 mutation affects recognition, and S1-4 sensitize the responsiveness.
Sensitization Requires an Intact P Loop. The nucleotide-binding P loop, also known as the Walker A motif, is essential for the function of most (6, 34, 41) but not all NB-LRRs (42, 43) . To find out whether the S1-4 mutants are P loop-dependent, we introduced three inactivating mutations (G175A, K176R, T177A) (6, 42) into the invariant nucleotide-binding GKT motif of the P loop in the autoactive RxS1234 background.
All three P-loop mutations suppressed autoactivity, but only the K176R mutation completely abolished RxS1234-induced necrosis (Fig. 4C) . From Western blots, we rule out that this loss of function is due to protein stability (Fig. 4D) . The results are consistent with nucleotide binding as an essential step in RxS1234 autoactivity. Because the S1, S2, S3, and S4 mutations are in close proximity to the nucleotide-binding pocket (Fig. 2B) , they could increase activation sensitivity by affecting the affinity or catalysis of the ATP/ADP nucleotide (4).
Transgenic Plants Are Resistant to PopMV. To determine whether the sensitized versions of RxM1 provide broad-spectrum resistance to PVX and PopMV strains without the systemic necrosis, we generated transgenic lines of N. benthamiana expressing RxS1*M1, RxS2*M1, RxS3*M1, and RxS4M1 and compared them with Rx and RxM1. When challenged with PopMV, the wild-type and Rx plants developed mosaic symptoms and mild stunting whereas the RxM1 plants exhibited trailing necrosis, as previously reported (27) . In contrast, the RxS1*M1, RxS2*M1, RxS3*M1, and RxS4M1 transgenic lines showed resistance against PopMV infection. The resistance in the RxS2*M1, RxS3*M1, and RxS4M1 plants was variable, and these plants exhibited complete resistance or trailing necrosis in the T1 generation (progeny of primary transformants) when challenged with PopMV. RxS1*M1, however, displayed full resistance to PopMV (Fig. 5A) . RT-PCR of systemic leaf tissue from RxS1*M1 plants inoculated with PopMV revealed a perfect anticorrelation between expression of the transgene and accumulation of PopMV, demonstrating cosegregation of transgene and resistance to PopMV (Fig. 5B) . The RxS1*M1-expressing plants were also fully resistant to both strains of PVX (CP TK and CP KR ), like RxM1 (Fig. S6) .
Discussion
An initial interpretation of Rx and other NB-LRR proteins was that the LRR domain would carry out the elicitor recognition function in disease resistance and that the amino-terminal domains, including NB, would mediate the response phase leading to intracellular signaling and disease resistance. In this and a previous study (27) , we provide strong evidence for these two separate phases of Rx-mediated resistance. The S1-4 mutations identified here, for example, could activate an HR in our transient assay in the absence of elicitor (Fig. 4 and Fig. S5 ), and they have the predicted properties of response-phase mutants. Conversely, the modified HR responses of the previously identified M1-3 mutations were absolutely dependent on the presence of elicitor and have the properties of recognition-phase mutants.
With Rx and other NB-LRRs, there is evidence that the LRR plays some role in recognition, as predicted by the original model, because sequence variants in that domain influence the specificity of the disease resistance (9-11, 27, 44) . Similarly, it is likely that the amino-terminal domains, including NB, have some role in the response phase, as predicted by the original model (17, 45, 46) . Supporting this idea, we describe five mutations affecting the structure of the conserved nucleotide-binding pocket (formed by the NB-ARC domains; Fig. 2B ) that increased activation sensitivity of Rx-mediated responses. However, other analyses have blurred the relationship between structure and function of NB-LRR proteins (12, 47, 48) , and it no longer seems likely that there is a clean separation of the activation and recognition functions between the amino-and carboxyl-terminal domains. Our data do not rule out that recognition and response functions are dispersed throughout the structure of Rx.
The Effect of the N-Terminal Mutations on Activation of Rx in the
Response Phase. That individual mutants S1, S2, S3, and S4 increase activation sensitivity of Rx was only evident when they were overexpressed or expressed together with RanGAP2 (Fig.  S5) . However, when the five mutations were combined in RxS1234, the Rx HR was activated even when the protein was expressed from the native Rx promoter and without RanGAP2 coexpression (Fig. 4 A and B) . This effect could be explained in terms of an ATPase that mediates the switch between ATP-bound "on" and ADP-bound "off" NB-LRR activation states (4). These two forms of Rx would be in dynamic equilibrium and, in the absence of coat protein elicitor with wild-type Rx, the pool would be predominantly in the inactive state. The S1, S2, S3, and S4 mutations could each shift the balance toward the activated form so that, in RxS1234, it is likely that the full activation was achieved without any further stimulus from overexpression of Rx or RanGAP2. The same mechanism is indicated by the increased preference for binding ATP (49) in an autoactive version of the Flax M NB-LRR. Similarly, an autoactive version of the tomato NB-LRR protein, I-2, is impaired in nucleotide hydrolysis (50) . Ultimately, it will be necessary to perform biochemical tests on these versions of Rx to test these hypotheses.
Several other observations are consistent with this mechanistic explanation of the S1-4 mutants. For example, the requirement for an intact P loop (Fig. 4 C and D) indicates an essential role of nucleotide binding for the S1-4 mutations to have their effect. An intact P loop has also been shown to be required for other autoactive NB-LRR variants, including Rx and I-2 (38, 50) . Similarly, the proximity of the S1-4 mutations to the nucleotidebinding pocket (Fig. 2B ) is also consistent with an effect on ATP turnover. However, we cannot exclude the possibility that the mutations affect the interaction with the LRR domain or downstream signaling components (18, 19, 40) .
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RxS1234 Rx Artificial and Natural R Gene Evolution in Crop Protection. In this paper, we have used the RxM1 mutant to illustrate the tradeoff of costs and benefits in disease resistance. We show that a costspreading necrosis following PopMV infection-can be mitigated by secondary mutation and, if PVX were a problem in crops, it may well be that one or more of the RxS1-4M1 genes would be more useful than the natural alleles of Rx: they would confer resistance against both the CP TK and CP KR strains of PVX. However, the crops with evolved RxM1 alleles would need to be tested against a range of pathogens to rule out that new costs had been introduced.
The idea that the LRR and N-terminal domains must coevolve has been indicated by recombination experiments showing incompatible interactions between domains of closely related NBLRRs (20, 47) , and it may well be that other NB-LRR genes could be enhanced by stepwise artificial evolution as with RxM1 (51). The NB-LRRs in crops would have originated in wild species where the tradeoff of costs and benefits selected in the natural environment would have influenced the resistance phenotype. However, the optimal tradeoff in a natural environment may not be the same as in a managed agricultural setting, and it could be that the range of useful R genes for crop protection could be expanded by stepwise artificial evolution. In the first stage, a gene could be evolved in one domain to derive mutants in which the degree or specificity of resistance is modified. The mutants could then be further refined by mutation of a second domain to ensure that costs have been minimized. This approach might be particularly useful if resistance-breaking strains of a pathogen have emerged or if the resistance of the natural R gene is too weak to contain the pathogen. Alternatively, broad recognition could be paired with a "reduced" level of activation sensitivity to minimize the resistance tradeoff with plant growth (25) and ensuring that only very strongly recognized pathogen signals initiate a defense response. As we have shown that these S mutations can act independently of the broad recognitionconferring mutation in the LRR (Figs. 3A and 4B) , we can begin to fine-tune the balance between NB-LRR recognition and response functions.
How does our sequential in vitro selection approach compare with evolution in natural populations? According to Ossowski et al. (52) , the spontaneous mutation rate of Arabidopsis is estimated at 7 × 10 −9 nt changes per site per generation, ∼1 × 10
changes per 1.5-kb region per generation. Here we surveyed around 7,500 changes (1,500 clones at an average mutational frequency of 5 changes per molecule, 5 × 1,500 = 7,500) across a 1.5-kb region. Therefore, this study surveys the mutational spectrum equivalent to ∼750 million Arabidopsis plants (7,500/1 × 10
) in each round of mutation: The combined effect of a stepwise strategy is therefore equivalent to much larger populations.
An additional consideration is that the selection in our artificial evolution approach is much more stringent and targeted to the NB-LRR of interest than selection on individual NB-LRRs in a natural plant population (53) . Stepwise artificial evolution therefore represents a powerful approach to modulate NB-LRR characteristics that is more efficient in time and space than evolution in the field. This study demonstrates that a heuristic approach, combining in vitro directed evolution and structural modeling, can be used to design improved NB-LRRs for use in crop protection.
Materials and Methods
Plasmids. The constructs used are described in SI Materials and Methods.
Homology Modeling. Homology modeling has been described previously (20) . Images were generated using PyMOL software, http://www.pymol.org/.
Transient Expression. Agrobacterium tumefaciens GV3101 or C58C1 was infiltrated in 3-to 4-wk-old N. tabacum or N. benthamiana plants using similar methods described previously (32) .
Chlorophyll Content Assay. Based on ref. 33, the protocol is described in detail in SI Materials and Methods.
Western Blots. Total protein was extracted from infiltrated N. tabacum tissue using methods described by ref. 54 . HA-tagged Rx was detected using an anti-HA rat monoclonal antibody (clone 3F10; Roche 1867423) and goat antirat (LI-COR; IRDye 800CW, 926-32219) secondary antibody and visualized on a LI-COR Odyssey CLx. Transgenic Plants. Previously described N. benthamiana transgenic lines used in this study were wild type, Rx (RxH3), RxM1 (2/227 2B10), and RxM123 (GR3 F11) (27) . RxS1-4*M1 transgenic N. benthamiana were generated by leaf disc transformation (55) .
RT-PCRs. Total RNA was extracted from noninoculated leaf tissue using TRIzol reagent, and cDNA was generated using random hexamer-primed RT synthesis (Invitrogen; 18080-051). RT-PCR was performed using gene-specific primers (Table S2) . 
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SI Materials and Methods
Plasmid Construction. Constructs driven by the native Rx genomic and 35S promoters are based on pB1:Rx-HA (1) and pBIN61, respectively (2). The RanGAP2 construct, SLDB3154, was described previously (3). Plasmids used for leaf disc transformation were based on pGreenII 0029 (http://www.pgreen.ac.uk). Site-directed mutagenesis was performed using mutagenic primers and standard overlap PCR techniques (Table S2) . Error-prone PCR products were cloned into the XbaI and ApaLI sites of pB1:RxM1-HA.
Error-Prone PCR. The GeneMorph II kit (Aligent Technologies) was used because it provides a balanced ratio of transitions to transversions. Sequencing over 150 clones revealed an average mutations frequency of 3.44 nt, and 2.55 amino acid changes per kb (95% confidence intervals of ±0.319 and ±0.311, respectively).
Infectious Clones. Infectious clones for the PVX CP4 strain (encoding CP TK ) and the PVX HB strain (encoding CP KR ) were pGR106 and pGR103, respectively, as described previously (4). We generated an infectious clone for PopMV; oligo-dT-primed RT cDNA from sap-inoculated PopMV-infected tissue (2) was used as a template to amplify the full virus using KOD Xtreme Hot Start DNA Polymerase (Novagen; 71975-3) using the following primers: forward 5′-AATGGATCCGGACAATACAAAACACCTCAAATATAA-CAA-3′ and reverse: 5′-AATGAATTCTTTTTTTTTTTTTTTT-TTTTGGTTAAAATATATTAAAAATCCAAATTA-3′. The resulting 8.7-kb product was cloned into pGEM-T Easy (Promega). The viral sequence was then excised and cloned into a pGreenII 0000-based plasmid containing the 35S promoter and Nos terminator, resulting in the PopMV infectious clone, pGR256.
Chlorophyll Content Assay. This protocol is based on the method described by Pruzinská et al. (5) . To measure the level of chlorophyll content of a leaf tissue sample, three leaf discs (e.g., 4-mm radius, from Eppendorf lid) were placed in a 1.5-mL Eppendorf tube containing 1 mL of dimethylformamide (DMF). Five replicates were included for each sample type. The leaf discs were fully submerged in the DMF solution. The chlorophyll was allowed to dissolve into the DMF solution by incubating overnight at 4°C. Three hundred microliters of sample solution was mixed with 600 μL of DMF in a fresh Eppendorf tube (two volumes of DMF per volume of sample). The absorbance (A) was read on a spectrophotometer at 647 and 664.5 nm using a glass cuvette. Single-amino acid change constructs corresponding to each of the mutations identified in RxS1*M1, RxS2*M1, and RxS3*M1 were generated and coexpressed with PVX-CP TK . These constructs also contain the M1 (N846D) mutation in the LRR. All single-amino acid change constructs produce functional proteins that produce a strong necrotic response to PVX-CP TK when coexpressed in N. tabacum (pictures were taken 4 dpi). (C) To determine which amino acid changes are responsible for the PopMV-CP response, we coexpressed the single-amino acid change constructs with PopMV-CP in N. tabacum leaf segments. On the opposite side of the leaf, we coexpressed the original clone with PopMV-CP as a positive control. A chlorophyll content assay was used to determine the level of necrosis 5 dpi. For RxS1*M1, the M293L mutation was necessary and sufficient to cause similarly reduced levels of chlorophyll content; for RxS2*M1, the T178A mutation was responsible; for RxS3*M1, both the N147D and V337A mutations were required (indicated by red asterisks). Black bars represent original constructs, and gray bars represent the individual amino acid change constructs. Each bar represents an average of five biological replicates. Error bars represent 95% confidence intervals. 5  T535A, A654T, C871T, A877T, G1446T  4  L179M, R291C, M293L, K482N   2  B/B1  6  C371T, A489G, A723G, C997A, A1182T, A1363T  3  T124I, L333I, S455C   E  0  6  4  D  ,  T  7  6  1  S  2  A  0  8  3  1  T  ,  A  9  9  4  T  2  6  D  /  C  3   L  4  7  1  I  1  C  0  2  5  A  1  9  H  /  D  4   5  E/A8  5  G382A, T864A, T1081A, T1115C, T1234T  5  V128I, H288Q, S361T, M372T, P412S 6 E/G10 4 G386T, C888T, G1264A, G1370C 3 S129I, G422R, G457A T861del, T1007A  2  P287del, V336E   I  3  7  3  R  ,  I  6  8  S  ,  L  8  4  H  3  T  8  1  1  1  G  ,  T  7  5  2  G  ,  T  3  4  1  A  3  6  D  /  M  1  2   C  5  9  2  F  ,  K  9  3  1  E  2  G  4  8  8  T  ,  A  5  1  4  G  2  6  A  /  N  2  2   Table showing the 22 candidates, out of 1,500, isolated from the first round of the screen where RxM1 N-terminal variants were retained if they produced a necrotic response when coexpressed with PopMV-CP. The table shows the name of the clones and the number and nature of the nucleotide and amino acid changes. Clones that induce an autoactive necrotic response when coexpressed with GPF are shown on a white background, whereas the nonautoactive clones that are used for further analysis in the study (RxS1 * M1, RxS2 * M1, RxS3 * M1, RxS4M1) are highlighted in yellow. The M1 (N846D) mutation is not shown. *Twenty-two base pairs upstream of the ATG start in pB1:RxM1-HA plasmid.
